SLDB Return on Tangible Equity | Solid Biosciences Inc.

Solid Biosciences Inc. (SLDB) Return on Tangible Equity

2026-06-30: Return Tang Equity -55.36%.
2026-03-31: Return Tang Equity -51.26%.
2025-12-31: Return Tang Equity -96.84%.
2025-09-30: Return Tang Equity -76.69%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-55.36%
2026-03-31	-51.26%
2025-12-31	-96.84%
2025-09-30	-76.69%
2025-06-30	-59.66%
2025-03-31	-47.43%
2024-12-31	-90.86%
2024-09-30	-61.33%
2024-06-30	-46.93%
2024-03-31	-42.83%
2023-12-31	-75.91%
2023-09-30	-62.92%
2023-06-30	-55.13%
2023-03-31	-49.36%
2022-12-31	-40.62%
2022-09-30	-62.43%
2022-06-30	-53.63%
2022-03-31	-43.46%
2021-12-31	-34.67%
2021-09-30	-33.55%
2021-06-30	-32.87%
2021-03-31	-31.03%
2020-12-31	-66.84%
2020-09-30	-444.37%
2020-06-30	-262.32%
2020-03-31	-202.52%
2019-12-31	-146.44%
2019-09-30	-98.86%
2019-06-30	-126.87%
2019-03-31	-89.30%
2018-12-31	-59.75%
2018-09-30	-46.43%
2018-06-30	-38.11%
2018-03-31	-30.84%
2017-12-31	87.95%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-96.84%
2024-12-31	-90.86%
2023-12-31	-75.91%
2022-12-31	-40.62%
2021-12-31	-34.67%
2020-12-31	-66.84%
2019-12-31	-146.44%
2018-12-31	-59.75%
2017-12-31	87.95%
2016-12-31	56.85%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Attovia Therapeutics, Inc. (ATTO)	United States	$0.828B
4D Molecular Therapeutics, Inc. (FDMT)	United States	$0.733B	-4.10
Candel Therapeutics, Inc. (CADL)	United States	$0.885B	-8.86
Sana Biotechnology, Inc. (SANA)	United States	$0.886B	-4.92
Odyssey Therapeutics, Inc. (ODTX)	United States	$0.960B
Aura Biosciences, Inc. (AURA)	United States	$0.639B	-5.61
Cullinan Therapeutics, Inc. (CGEM)	United States	$0.993B	-5.72
Monte Rosa Therapeutics, Inc. (GLUE)	United States	$1.002B	-12.81
Allogene Therapeutics, Inc. (ALLO)	United States	$0.574B	-4.33
Prime Medicine, Inc. (PRME)	United States	$0.557B	-3.54